These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35117796)

  • 1. Clinical value and feasibility of ISET in detecting circulating tumor cells in early breast cancer.
    Zeng H; Veeramootoo JS; Ma G; Jiang Y; Wang J; Xia T; Liu X
    Transl Cancer Res; 2020 Jul; 9(7):4297-4305. PubMed ID: 35117796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
    Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
    Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two detection systems for circulating tumor cells among patients with renal cell carcinoma.
    Bai M; Zou B; Wang Z; Li P; Wang H; Ou Y; Cui K; Bian J; Li S; Xu X
    Int Urol Nephrol; 2018 Oct; 50(10):1801-1809. PubMed ID: 30120680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
    Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
    Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analogous detection of circulating tumor cells using the AccuCyte
    van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
    Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.
    Hofman V; Ilie MI; Long E; Selva E; Bonnetaud C; Molina T; Vénissac N; Mouroux J; Vielh P; Hofman P
    Int J Cancer; 2011 Oct; 129(7):1651-60. PubMed ID: 21128227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating stage III-IV gastric cancer tumor cells based on isolation by size of epithelial tumor: using the circulating tumor cell biopsy technology.
    Lu R; Chen Q; Liu X; Shen S; Pan Z; Shi C
    Transl Cancer Res; 2019 Aug; 8(4):1342-1350. PubMed ID: 35116877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent Approaches.
    Li H; Song P; Zou B; Liu M; Cui K; Zhou P; Li S; Zhang B
    Medicine (Baltimore); 2015 Sep; 94(38):e1565. PubMed ID: 26402816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch
    Tamminga M; Andree KC; Hiltermann TJN; Jayat M; Schuuring E; van den Bos H; Spierings DCJ; Lansdorp PM; Timens W; Terstappen LWMM; Groen HJM
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32272669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances and prospects in the isolation by size of epithelial tumor cells (ISET) methodology.
    Ma YC; Wang L; Yu FL
    Technol Cancer Res Treat; 2013 Aug; 12(4):295-309. PubMed ID: 23448577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients.
    Ilie M; Szafer-Glusman E; Hofman V; Long-Mira E; Suttmann R; Darbonne W; Butori C; Lalvée S; Fayada J; Selva E; Yu W; Marquette CH; Shames DS; Punnoose E; Hofman P
    Oncotarget; 2017 Apr; 8(16):26112-26121. PubMed ID: 28212540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion.
    Chinen LT; Mello CA; Abdallah EA; Ocea LM; Buim ME; Breve NM; Gasparini JL; Fanelli MF; Paterlini-Bréchot P
    Onco Targets Ther; 2014; 7():1609-17. PubMed ID: 25258541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer.
    Matikas A; Voutsina A; Lagoudaki E; Hatzidaki D; Trypaki M; Stoupis G; Tzardi M; Mavroudis D; Georgoulias V
    Transl Oncol; 2017 Aug; 10(4):693-698. PubMed ID: 28692881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of circulating tumor cells in patients undergoing surgery for esophageal cancer and a specific confirmation method.
    Zhao Y; Zhao S; Chen Y; Dong X; Peng C; Sun Q; Shan L; Wang Z; Zhao X
    Oncol Lett; 2019 Apr; 17(4):3817-3825. PubMed ID: 30881502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of circulating tumor cells in prospective clinical trials for NSCLC patients - standardization of the pre-analytical conditions.
    Ilie M; Hofman V; Leroy S; Cohen C; Heeke S; Cattet F; Bence C; Lalvée S; Mouroux J; Marquette CH; Hofman P;
    Clin Chem Lab Med; 2018 May; 56(6):980-989. PubMed ID: 29397019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of two methods for the detection of circulating tumour cells in patients with oral cavity cancer.
    Curtin J; Wong G; Wang W; Thomson P; Lam AK; Choi SW
    J Oral Pathol Med; 2022 Mar; 51(3):249-255. PubMed ID: 34586677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
    Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
    BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A label-free microfluidic chip for the highly selective isolation of single and cluster CTCs from breast cancer patients.
    Zhang X; Lu X; Gao W; Wang Y; Jia C; Cong H
    Transl Oncol; 2021 Jan; 14(1):100959. PubMed ID: 33248414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer.
    Buim ME; Fanelli MF; Souza VS; Romero J; Abdallah EA; Mello CA; Alves V; Ocea LM; Mingues NB; Barbosa PN; Tyng CJ; Chojniak R; Chinen LT
    Cancer Biol Ther; 2015; 16(9):1289-95. PubMed ID: 26252055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.